Cargando…
Immunotherapy in Biliary Tract Cancer: Worthy of a Second Look
Although immune checkpoint inhibitors (ICIs) have revolutionized the treatment landscape of several malignancies, the role of immunotherapy in biliary tract cancer (BTC) is currently under investigation and ICIs are still looking for their niche in this setting. In this Editorial, we discuss recentl...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791443/ https://www.ncbi.nlm.nih.gov/pubmed/32806956 http://dx.doi.org/10.1177/1073274820948047 |
_version_ | 1783633605540446208 |
---|---|
author | Ricci, Angela Dalia Rizzo, Alessandro Brandi, Giovanni |
author_facet | Ricci, Angela Dalia Rizzo, Alessandro Brandi, Giovanni |
author_sort | Ricci, Angela Dalia |
collection | PubMed |
description | Although immune checkpoint inhibitors (ICIs) have revolutionized the treatment landscape of several malignancies, the role of immunotherapy in biliary tract cancer (BTC) is currently under investigation and ICIs are still looking for their niche in this setting. In this Editorial, we discuss recently published data regarding ICIs in BTC, with a particular focus in terms of selection of patients and biomarker-driven trials. |
format | Online Article Text |
id | pubmed-7791443 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-77914432021-01-15 Immunotherapy in Biliary Tract Cancer: Worthy of a Second Look Ricci, Angela Dalia Rizzo, Alessandro Brandi, Giovanni Cancer Control The Evolving Landscape of Systemic Treatment in Biliary Tract Cancer: Is It Time For Revolution Although immune checkpoint inhibitors (ICIs) have revolutionized the treatment landscape of several malignancies, the role of immunotherapy in biliary tract cancer (BTC) is currently under investigation and ICIs are still looking for their niche in this setting. In this Editorial, we discuss recently published data regarding ICIs in BTC, with a particular focus in terms of selection of patients and biomarker-driven trials. SAGE Publications 2020-08-17 /pmc/articles/PMC7791443/ /pubmed/32806956 http://dx.doi.org/10.1177/1073274820948047 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | The Evolving Landscape of Systemic Treatment in Biliary Tract Cancer: Is It Time For Revolution Ricci, Angela Dalia Rizzo, Alessandro Brandi, Giovanni Immunotherapy in Biliary Tract Cancer: Worthy of a Second Look |
title | Immunotherapy in Biliary Tract Cancer: Worthy of a Second
Look |
title_full | Immunotherapy in Biliary Tract Cancer: Worthy of a Second
Look |
title_fullStr | Immunotherapy in Biliary Tract Cancer: Worthy of a Second
Look |
title_full_unstemmed | Immunotherapy in Biliary Tract Cancer: Worthy of a Second
Look |
title_short | Immunotherapy in Biliary Tract Cancer: Worthy of a Second
Look |
title_sort | immunotherapy in biliary tract cancer: worthy of a second
look |
topic | The Evolving Landscape of Systemic Treatment in Biliary Tract Cancer: Is It Time For Revolution |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791443/ https://www.ncbi.nlm.nih.gov/pubmed/32806956 http://dx.doi.org/10.1177/1073274820948047 |
work_keys_str_mv | AT ricciangeladalia immunotherapyinbiliarytractcancerworthyofasecondlook AT rizzoalessandro immunotherapyinbiliarytractcancerworthyofasecondlook AT brandigiovanni immunotherapyinbiliarytractcancerworthyofasecondlook |